Abstract Submission

The International Narcotics Research Conference 2011


DATA BLITZ INFO! Submit now!

 

POSTER PRESENTATION INFO:

poster size: posters should be no larger than 4 ft high x 6 ft wide

pushpins to mount your poster will be supplied

You will find your abstract (poster board) number in the

Final Complete CPDD/INRC Program


WEDNESDAY POSTER SESSION

CPDD/INRC Poster Session III

Great Hall 3-6

(Lunch) 12:00 - 2:00 PM

Odd-numbered posters manned first hour;

Even-numbered, second hour

Set-up time begins Tuesday 1:00 P.M.

Must be removed by Wednesday 2:00 P.M.


THURSDAY
POSTER SESSION

CPDD/INRC Poster Session IV

Great Hall 3-6

(Breakfast) 7:30 - 9:30 AM

Odd-numbered posters manned first hour;

Even-numbered, second hour

Set-up time begins Wednesday 3:00 P.M.

Must be removed by Thursday 1:00 P.M.

 

ABSTRACT SUBMISSION INFO:

Deadline: March 1, 2011

As many active participants as possible are welcome at INRC meetings. Abstracts should be provided for poster presentations, as well as all oral presentations including Symposia, Founder, and Plenary lectures. If you haven't been invited to give an oral presentation, please plan on preparing a poster (see below). Some authors will be invited to give a short oral presentation after submission of an abstract.

Abstract Submission Instructions

Abstracts may only be submitted electronically for this meeting. Please note the abstract submission deadline of March 1, 2011!

All abstracts can be no more than 2300 characters including names and affiliation!!

Please type up your abstract according to this sample:

Involvement of GLT-1, a glial glutamate transporter, in physical and psychological morphine dependence
T. Nakagawa (1), T. Ozawa (1), Y. Sekiya (1), H. Ueda (2), M. Satoh (1) (1)Dept. of Mol. Pharmacol., Grad. Sch. of Pharmaceut. Sci., Kyoto Univ., Kyoto, Japan, (2)Dept. of Mol. Pharmacol. and Neurosci., Sch. of Pharmaceut. Sci.,Nagasaki Univ., Nagasaki, Japan

We previously reported the changes in the expression of the glial glutamate transporter GLT-1 mRNA in some brain regions of morphine-dependent rats. In this study, we examined the roles of GLT-1 in physical and psychological dependence on morphine......blah, blah, blah, blah, blah, blah, blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,...etc, etc ........................................... DON'T FORGET to acknowledge your funding source at end!!

Do NOT use Greek symbols but spell out symbols as much as possible. Use character count tools! Keep total characters (including titles, names, institutions & spaces) to no more than 2300 characters.

File type: Word.doc is preferred.
Font: Times or Times New Roman, 12pt font.
Size: No more than 2300 characters including titles, authors, and spaces.

Please indicate in your email if you are willing to present an oral presentation if selected.

Symposia, Founder, and Plenary lecturers abstracts can be 2300 characters at most.

Abstract Publication
Abstracts will be available for viewing at the INRC website and in the abstract book distributed at the Meeting.

IMPORTANT! Please name your abstract word file with your last name,
then initials of your other names. (for example "stevenscw.doc" for "Craig W. Stevens")

Please note in your email body if you are a graduate student, postdoctoral fellow, or young investigator ('young' defined as within 10 years of your Ph.D.)

Save your abstract document as a Microsoft word doc, attach it to an email with the subject
line as "INRC Abstract", and send to:
INRCabstracts2011@gmail.com

if you have questions please send them to
Dr. Sari Izenwasser at: sizenwasser@med.miami.edu

As further information becomes available, announcements will be made to the INRC-L email list. If you are not already on the INRC-list server, please send your current e-mail address, full name and institutional affiliation to:

Craig W. Stevens, Ph.D.
INRC Information Officer
at:
cw.stevens@okstate.edu

 

 

 

 

 

Comments or suggestions can be emailed to the INRC Information Officer at:  cw.stevens@okstate.edu
This site supported by server space and system administration generously donated by OSU-Center for Health Sciences, Tulsa, OK, U.S.A.